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CHAPTER 1
INTRODUCTION
It has long been recognized that there exists a close relationship between the skin
and the immune system. The skin, acting as the barrier between the body's external and
internal environment, is bombarded daily with numerous insults, both physical and biologi-
cal. Although it has long been recognized as a physiochemical barrier and an organ of
temperature control, only in the past 20 years have the immunocompetent attributes of the
skin come to be appreciated. First, the true role of epidermal Langerhans cells (LC) as an-
tigen presenting cells began to be real1zed by 1978 (98), after originally having been
thought to be a part of the nervous system. Another finding that gave credence to the idea
of the skin having immunologic function was the finding of certain T cell malignancies
with an inclination toward infiltrating the skin (100). Streilein was the first to give the
idea of this relationship between the skin and immune system a name -- Skin-Associated
Lymphoid Tissue or SALT (104) -- and he included within this system keratinocytes, the
growing layer of the epidermis; the LC, the major antigen-presenting cell of the epidermis;
skin-seeking T lymphocytes; endothelial cells, that direct homing T cells; and draining
lymph nodes (104, 101).
However, in 1983, a discovery was made that would force researchers to slightly
alter their concept of the SALT system. Groups in both Dallas and Vienna, Austria re-
ported a cell population in mouse epidermis that bore a dendritic morphology and Thy-1
cell surface glycoprotein, but no IA molecules (10, Ill). These cells did not resemble any
other cell present in the epidermis and it was impossible at the time to place them in any
type of classification scheme, so these cells were simply referred to as Thy-l + dendritic
epidermal cells (10, 111).
Within a few years, however, much was learned about these cells, the most signifi-
cant being that they possessed a T cell receptor (TCR), upon where they were renamed
dendritic epidermal T cells (DETC). This TCR was found to be of the CD3-associated
(97) ylB type, rather than the aJf3 heterodimer, as is found on most circulating peripheral T
cells (53), and it lacked both the mature T cell surface markers CD4 and CD8 (8). De-
spite their lack of these markers, DETC were found to proliferate in the presence of the T
cell mitogen Concanavalin A and also Interleukin-2 (IL-2) (72, 106), as well as anti-CD3
monoclonal antibody (MoAb), phorbol ester and calcium ionophore (72, 41, 110), Also
unlike most T cells, DETC exist as non-circulating cells in the suprabasallayer of the epi-
dermis, where they constitute only 0.8-2% of cells there (8, 108), Radiation chimera stud-
ies have shown that, along with LC, DETC are of bone marrow origin (9, 17), Evidence
has also shown that they are dependent on the thymus for complete development (71, 58,
42) which lends additional support to the DETC being of the T cell lineage.
Much has been learned about DETC since their discovery in 1983 (8, 108, 107),
but many questions still persist and at the present time, their physiologic role has not been
elucidated, Also interesting is the fact that, to date, no resident ylB+ cells with a dendritic
morphology have been found in the epidermis of any mammalian species, including hu-
mans. One of the keys to understanding the true role of these cells lies in the determina-
tion of the antigen DETC recognize, as their TCR is characterized by very limited
diversity (40, 5), even to the point of being virtually monomorphic (107). This suggests
that the number of ligands that the DETC can recognize is extremely limited and some in-
vestigators have suggested that there is only a single physiologic ligand for the DETC (4).
The ylB TCR is thought to be more primitive than its a/f3 counterpart, as evidenced by the
fact that y and B chains are rearranged and expressed earlier than the a/f3 heterodimer
(46), and because of this ontogenic difference, were termed TCRI and TCR2,
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respectively. Since most ylf>+ T cells reside in various epithelial compartments, it has been
proposed that ylo T cells form a first line of defense against invading pathogens and may
playa crucial role in immune surveillance (46).
To maintain and coordinate this complex system of cutaneous immune responders
is an interwoven network of cytokine production. To illicit an immune response in the
skin and to eliminate the offending antigen, cells of the SALT system must work in con-
junction with one another and coordinate their actions. Keratinocytes bear the largest bur-
den of supplying soluble protein signals as nonspecific activators for other cells in a
cutaneous immune response. This is certainly their primary immune function, but it could
be argued that their role in capturing antigen is rather significant, although this point re-
mains a topic of debate. Keratinocyte-derived Interleukin-1 (IL-1), and to a lesser extent
tumor necrosis factor, have a significant effect in mediating inflammatory and contact hy-
persensitivity reactions in the skin. Both cytokines have been implicated in upregulation of
endothe1ial cell adhesion molecules (88) and may be necessary primary signals in LC mi-
gration from the epidermis. IL-I has proved important as an autocrine stimulatory factor
for neighboring keratinocytes and a chemoattractant of T cells (] 00). Little is known
about what signaling effects epidermal keratinocytes have on DETC. It is known that
IL-7 from keratinocytes serves as a growth factor for DETC (62) and DETC will migrate
toward PAM. 212 keratinocyte culture supernatants, but not toward keratinocyte cyto-
kines administered individually (24)
Immunobiology of the Skin
The role of the skin as a protective organ has long been known, but in recent
years, much has been learned about the skin's relationship with the immune system Al-
though the skin is effective acting as a physiochemical barrier to environmental insults and
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invading organisms, it cannot keep all pathogens from getting through its layers. There-
fore, the skin, along with its draining lymph nodes, must act as an active immune organ in
fighting against external infections and cutaneous neoplasms (88), althewhile maintaining
its physiologic functions.
The concept of cutaneous immunobioiogy was first reported by Alexandre Bes-
redka in 1925 (11) when she pointed out the existence of organ-specific immunity, where
she wrote two books on the subject (15). In 1970, a group published an article (31) in
which they stated that the skin was a first-level lymphoid organ, comparable to the primary
lymphoid status of the thymus (15). Much of what is known about cell-mediated immu-
nity came about through delayed type hypersensitivity skin reactions in experimental as-
says (100). The idea of organ or tissue-specific immunity was first documented for the
respiratory tract as BALT (or bronchial-associated lymphoid tissue) (12) and the gastroin-
testinal tract as GALT (gut-associated lymphoid tissue) (39), but StreiJein's definition of
skin-associated lymphoid tissue or SALT (l 04), was the first documentation suggesting
resident keratinocytes, Langerhans cells, epidermotropic T cells, dermal endothelial cells
and draining lymph nodes working together to provide immune protection to the skin.
The functional components of the SALT system work together to perform four ba-
sic functions, which are: (1) induction of primary immune responses to new cutaneous an-
tigens, (2) expression of immunity in the skin to previously encountered antigens, (3)
avoidance of deleterious responses to nonpathologic cutaneous antigens and (4) perform-
ing immune functions without compromising the skin's physiologic integrity (100). To do
this, the SALT system employs a number of cells within both the epidermis and the dermis
in the elicitation of contact hypersensitivity reactions. The most common type of antigens
that induce this type of contact hypersensitivity reaction are haptens such as pentadeca-
catechol from poison ivy and poison oak, nickel, chromate, and chemicals used to make
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rubber (83). As haptens, these substances are too small to illicit an immune response on
their own, but once they penetrate the epidermis, they probably bind to body proteins,
where they become active targets for cells of the immune system. First, keratinocytes
comprise the growing portion of the epidermis and constitute approximately 90% of the
cells found there. The outer layers of the skin are comprised of dead, densely packed
keratinocytes, but the basilar layers are made up of keratinocytes which produce a number
of immunologically-relevent cytokines and which are believed to create an appropriate en-
vironment for antigen uptake and recognition. Epidennal Langerhans cells (LC) are the
major antigen-presenting cell of the epidermis (while dermal macrophages and dendritic
ceHs play this role in the dermal layer) and are the only cells within normal, unperturbed
epidermis to constitutively express .rvrn:c class II molecules. The job of LC is to induce
primary T cell responses by binding to foreign antigens and migrating to draining lymph
nodes, where they present these antigens to T helper cells. The T lymphocytes to which
LC present their bound antigen may be found in regional somatic lymph nodes or in the
skin itself. These T lymphocytes find their way to the skin and ultimately, to the site of the
antigenic stimulation, by "sticking" to dermal and blood vessel endothelial cells which can
become activated to upregulate cell surface adhesion molecules that the skin-directed T
cells can recognize and bind. In the midst of all of these cellular interactions is a network
of cytokine release that coordinates immunological events within the skin that help drive
the immune response from initiation to resolution.
Layers of the Skin
The cutaneous membrane constitutes one of the four major types of organs of the
integumentary system, but is most-commonly referred to as the skin (43) As previously
stated, the skin acts as a physiochemical barrier that provides protection against harmful
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substances such as microorganisms, ultraviolet rays from the sun, toxins and harmful
chemicals. It also prevents water loss from deeper tissues, allows for sensory reception
through heavy innervation, excretes wastes, regulates body temperature (43) and, as just
described, mediates cutaneous immune responses.
The skin itself is divided into two major tissue layers, the epidermis and dermis,
which are separated by the dermal-epidermal junction. These tissues are held in place by a
layer of loose connective and fatty tissue termed the subcutaneous layer. The epidermis
comprises the outermost, avascular layer of the skin which is made up of stratified
squamous epithelium and is comprised of a number of layers -- layers that vary from re-
gion to region in the body. The deepest layer of the epidermis has access to nutrtents pro-
vided by blood vessels from the underlying dermis, and so, possesses cells that are capable
of growth and division. This layer is termed stratum germinativum or stratum basafe and
the cells here take on a columnar-cuboidal morphology. As keratinocytes -- the growing
cell population of the epidermis -- from this layer grow, they are pushed vertically, where
they flatten and acquire desmosomal connective junctions that help hold them to one an-
other to form a consistent epidermal covering. This thick layer is termed the stratum ,\pi-
nosum. Two more distal layers mayor may not be present, depending on the thickness of
the skin in a particular region. They are, a granular layer called the stratum granuiosum
and the stratum fucidum, which is found in palmar--plantar regions. As keratinocytes are
pressed even further away from the basal and spinous layers, their internal organelles and
nuclei disappear and they undergo a hardening process called keratinization, where a
tough, fibrous protein called keratin develops within the cell. This outermost layer of
densely-packed keratinized cells is called the stratum corneum and this is the final fate of
keratinocytes before they are sloughed off (95, 43). Binding the epidermis to the underly-
ing tissues is the dermis. The membrane separating these two skin regions is made up of
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both epidermal and dermal components in a series of folds, where both layers extend into
one another through small finger-like projections. This basement membrane is referred to
as the dermal-epidermal junction and this structure binds the epidermis to the dermis and
acts to prevent the movement of materials and cells across the junction (95). The dermis
itself is made up of collagen, elastic tissue and gel-like ground substance and can be di-
vided into two layers, the upper papillary layer and the lower reticular layer. Within
these layers can be found sensory and motor nerves, hair follicles, sweat and sebaceaous
glands, smooth muscle, and blood and lymphatic vessels. The dermis is essential for the
viability of the epidermis, as it cannot be maintained in culture for long periods of time
without dermal tissues present (95). The blood vessels of the dermis provide thermal
regulation to the skin and are also crucial for cell trafficking in cutaneous immune re-
sponses. Connective tissues of the dermis come from fibroblasts and it is the networking
of these tissues that give the skin its elasticity and toughness (95, 43). Underneath the
dermis lies the subcutaneous layer. This layer, composed mainly of loose connective and
adipose tissues, supplies blood to the skin through major blood vessels and also functions
as a heat insulator (43).
Langerhans Cells
It was in 1868 that a medical student by the name of Paul Langerhans inoculated
human skin with gold and discovered a population of dendritic epidermal cells, which he
originally ascribed as a cell of the nervous system (55). It took more than a century for re-
searchers to begin to understand the function of the cell that bears Langerhans' name.
Proof came about that Langerhans cells were not a part of the nervous system in the late
1960s (116) and eventually it was learned that these cells are of bone marrow origin (8)
and are believed to be of the monocyte/macrophage lineage (8). In the mid-1970s, it was
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realized that these cells possessed the ability to act as antigen presenting cells (98) and
much research has been done to corroborate this idea, as Langerhans cells (LC) have been
shown to possess a great ability to stimulate T cell responses within the skin and with
much greater efficiency than macrophages, splenic adherent cells and peripheral blood
monocytes(116, 49). This would be consistent with the fact the LC are the only cell in
normal epidermis to express surface IA antigens, the human corollary of which is ID...A-
DR (85). The ability of LC to induce these T cell responses comes from their ability to
migrate out of the epidermis to draining lymph nodes upon encountering antigen as shown
by depletion of these cells from the skin after hapten painting and that hapten-bearing
l\1HC class II+ cells appear in draining lymph nodes 24 to 48 hours after skin painting (8).
Also, it is believed that LC only reach their fun potential as antigen presenting cells after
having left the epidermis (15). Studies have implicated LC as being involved in contact
hypersensitivity reactions within the skin, showing that application of a chemical allergen
on the skin results in antigen-bearing dendritic cells in draining lymph nodes (26). Al-
though much of the antigen presented by LC is believed to take place in draining somatic
lymph nodes, if the appropriate T lymphocytes are already in or near the skin, antigen
presentation may take place within the skin itself (96). LC are also critical in graft rejec-
tion, as they represent the "passenger" leukocytes critical in allosensitization (103). Im-
portant to note, though, is the fact that application of haptens in LC-deficient skin leads to
suppresser T cell-mediated suppression (102), suggesting that it is the absence of LC, not
the LC themselves, that induce tolerance.
Langerhans cells constitute approximately 2-8% of the cells of the epidermis and
reside in its suprabasal region (88). LC can also be found in other epithelial tissue such as
the oral cavity, vagina, cervix and esophagus, as well as the dermis, and draining lymphatic
vessels and nodes (116). These cells are regularly distributed within the skin, although the
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density varies from region to region, and their dendrites intercalate between keratinocytes
to form a sort of immunological net, so that each LC covers an area greater than adjacent
epidermal cells (116). As previously stated, LC constitutively express MHC class II mark-
ers, but they also have receptors for the Fc portion of IgG, the complement component
C3b (l00) and are also ATPase positive (115). Unique to these cells is an organelle origi-
nally described by Birbeck (14). The exact function of this organelle remains undiscov-
ered at the present time, but it is the only reliable morphologic marker that the LC can be
identified by through electron microscopy (I 00).
Keratinocytes
Keratinocytes comprise the growing cell population of the epidermis and consist of
approximately 90% of the cells found there. These cells begin life in the basal layer of the
epidermis and as they proliferate, become pushed distally from that region, differentiating
into keratinized non-proliferative cells that form the outer layer of skin in direct contact
with the outside environment. Once they reach this layer, they are sloughed off and re-
placed by cells underneath, as this process repeats itsdf again and again. Over the past
few years, though, it has been realized that keratinocytes are not the immunologically-
silent cells scientists once thought they were, but possess properties that give them a vital
role in maintaining the immunologic integrity of the skin.
First and foremost, keratinocytes are able to produce a number of cytokines with a
wide range of immunologic influences. Under the appropriate circumstances, keratino-
cytes can produce IL-la and 13, IL-3, IL-6, IL-7, IL-8, IL-IO, IL-12, tumor necrosis fac-
tors alpha and beta (TNFa and f), granulocyte/macrophage colony stimulating factor
(GM-CSF), granulocyte colony stimulating factor (G-CSF), monocyte colony stimulating
factor (M-CSF), interferon alpha and beta (IFNa and J3), platelet-derived growth factor,
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fibroblast growth factor and transforming growth factors alpha and beta (TGFa. and P)
(65, 15, 100, 62). Few of these factors are expressed constitutively in vivo, but many can
be induced by a wide variety immunological insults as non-specific, pro-inflammatory sub-
stances, the most significant being IL-l. This cytokine, along with TNFa., has been shown
to increase :MHC class 11 and intercellular adhesion molecule (lCAM)-1 expression on LC
(7) and may well be one of the primary signals in inducing their migration from the epider-
mis (80). IL-l can cross the semi-permeable membrane of the dermal-epidermal junction,
as is demonstrated by its ability to be a strong chemoattractant to T cells (89) as well as to
upregulate surface adhesion molecules on the endothelial cells of post capillary venules of
the papillary and reticular dermis (57, 15). Keratinocytes also secrete cytokines that can
downregulate inflammatory responses. TGFp and prostaglandin E2 can inhibit inflamma-
tion by blocking the effects of both lL-1 and IL-2 and IL-IO downregulates MHC class II
expression and immune responses mediated by Th1 cells (23, 83)
Keratinocytes are also able to influence immune responses within the skin by
upregulating certain surface markers, namely MHC class II and ICAM-1. In non-inflamed
skin, keratinocytes only express MHC I antigens (EE), but in perturbed skin, IFNy se-
creted by T lymphocytes can upregulate class II MHC expression (112). There is some
speculation, however, as to the significance of class II MHC expression on these cells. No
studies have shown IA+ keratinocytes as possessing the ability to act as accessory cells in
antigen presentation (23). This may be due to the lack of the ability to process antigen as
shown in studies where IA+ keratinocytes could present viral peptides which required no
processing, but not intact viruses in which processing was necessary (23). Interestingly
enough, there is evidence suggesting that T cell recognition of antigen-derivatized kerati-
nocytes does occur, but that this recognition leads to clonal anergy, suggesting a role for
IA+ keratinocytes in the downregulation of immune responses (36). IFNy and TNFa.
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induce the expression of ICAM-l on keratinocytes, which may playa role in recruiting or
trapping immune cells to the site of antigenic challenge, as this molecule binds to lympho-
cyte function-associated antigen (LFA-l) expressed on activated T cells (88).
A phagocytic ability is demonstrated by keratinocytes, even much more so than
LC. It is theorized that antigen phagocytized by keratinocytes may be modified and rein-
troduced to the epidermal microenvironment, where they are picked up by the poorly-
phagocytizing LC in an essential first step in LC antigen presentation. However, internali-
zation of antigen by keratinocytes may prevent access of those antigens to other immune
cells and may actually prevent proper antigen presentation (l00).
Epidermotropic T Lymphocytes
It has been well-known that T lymphocytes playa major role in inflammatory, al-
lergic and autoimmune responses within the skin, but the discovery of certain T cell malig-
nancies with a propensity for infiltrating the skin, led researchers to believe that there
existed a population of actual skin-seeking lymphocytes (101). Research has demonstrated
that lymphoid cells recovered from mesenteric and peripheral lymph nodes display differ-
ent homing patterns, with mesenteric lymph node cells infiltrating the gut and peripheral
lymph node cells infiltrating the skin (38, 84). In 1990, Picker et al found a subset of pe-
ripheral T cells with cutaneous lymphocyte-associated antigen (CLA) by using the mono-
clonal antibody HECA-452, which binds to a 200 kD surface glycoprotein found on 16%
of peripheral blood T cells, but on 85% of T cells derived from various dermatological dis-
eases (81). CLA is expressed on approximately 43% of T lymphocytes in normal skin
(15). Along with the LFA-I-ICAM-l interactions of T cells with endothelial cells and
keratinocytes, this surface marker may well interact with E-selectin (formerly known as
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endothelial cell leukocyte adhesion molecule-I), which may act as an adhesion molecule
for cutaneous homing ofT cells.
There exists a vast difference in dispersion patterns of T cells in the skin, depend-
ing on the region. Of the total number of T lymphocytes in normal skin, 90% are located
in dermal perivascular regions. These numbers in the epidermis are 2% and most of these
cells are of the CD8+ phenotype (88). In the dermal regions, most of the cells are in the
activated state, as demonstrated by expression of HLA-DR antigens and IL-2 receptors.
Also, there are nearly equal numbers of CD4+ inducer and CD8+ cytotoxic/suppressor
cells, which are of the a/~ variety (16), clustered around post capillary venules in the der-
mis, but only CD8+ T lymphocytes are commonly found in "free" dermis, away from these
structures, occasionally venturing as far as the epidermis itself (100).
During initiation of an immune response in the skin, and subsequent migration of
antigen-derivatized LC, if the relevant memory T ceil is already located in the post capil-
lary region of the dermis, antigen presentation will most likely occur there. These induced
cells will then secrete IFNy, which causes upregulation of class Jl MHC and ICAM-I
molecules on keratinocytes and activates them to release pro-inflammatory cytokines such
as TNFa, GM-CSF, IL-3, IL-6 and most importantly, IL-l. This activation of keratino-
cytes can then induce the migration of non-antigen specific T cells from peripheral lymph
nodes, which home back to the site of the original challenge. If, however, the antigen in
question has not been previously encountered, LC will migrate to the regional lymph
nodes themselves, and there, present the antigen to naive T cells. Then, binding their lym-
phocyte homing receptors to the expressed adhesion molecules on endothelial cells, these
newly activated T cells will migrate to the skin to mediate an immune response. However,
Chin, Sackstein and colleagues have proposed, through studies involving lymphocyte traf-
ficking in psoriatic lesions, that upregulation of endothelial adhesion molecules may
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capture T lymphocytes with the appropriate receptors that are normally circulating
through the blood, implying that they may not even be T cells of the skin-seeking variety
(21, 22). It has been hypothesized that there is an "imprinting" of T cells based on the
unique tissue environment where the antigen is encountered, leading to tissue tropism
(31).
Ontogeny of DETC
When DETC were first discovered, scientists were unable to place them in any
particular classification scheme. The only indication of the potential lineage of these cells
came from the presence of the murine T cell differentiation marker Thy-Ion their surface,
hence the somewhat generic name, Thy-l + dendritic epidermal cell. The first key to un-
raveling the mystery of this particular cell population lie in discovering their origin. Bone
marrow chimera studies in A.KR mice unequivocally showed that Thy-l + cells of bone
marrow origin could infiltrate the epidermis of recipients, resulting in repopulation of allo-
geneic DETC, although reconstitution of significant numbers took much longer than simi-
lar studies employing LC (9, 17). Once this was established, the next issue to be dealt
with involved asking if these cells were derived from the thymus as precursor cells which
migrate into the epidermis during the neonatal period or whether they developed inde-
pendently of the thymus. Fetal thymocytes do bear the characteristic Vy3-Vol TCR of
DETC (108) and the disappearance of Vy3-Vol cells in the fetal thymus precedes the ini-
tial appearance of DETC in the epidermis (40, 42). A thymic dependence on DETC matu-
ration was observed by the fact that grafting of thymic lobes or injection of thymic
precursor cells resulted in the gradual appearance of CD3+, TCR-Vy3-V81 DETC in the
epidermis of athymic or Thy-l disparate mice, expanding in clusters and slowly becoming
more dendritic. This, along with the fact that CD3- or Vy3/V81- thymocytes failed to
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-repopulate the epidermis as CD3+ or Vy3Nol + DETC, supported the idea that DETC ar-
range and express their TCR before entering the epidermis (108, 8, 58, 28). Interestingly,
very few Thy-l+ cells are present in the epidermis of newborn mice and these cells are
CD45+, but CD3-. Only after a month are there cell densities in the skin comparable to
those of adults (107, 108) Elbe et ai, demonstrated this extra-thymic development from
precursor to mature CD45+/Thy-l +/CD3+ cells by grafting day 16 fetal skin onto athyrnic
or Thy-I-disparate adult rruce, whereupon fetal skin originally devoid of
CD3/TCR-bearing cells showed Thy-I +/CD3+/TCR Vy3+ cells in increasing numbers
over time of donor grafted, but not host, skin (78). This showed that although the precur-
sor cells of DETC originate in the thymus, their maturation is thymus-~ndependent, as it
takes place within the skin.
Functional and Structural Attributes of DETC
Surface Markers and T Cell Receptor
When first discovered in 1983, DETC were named Thy-I + dendritic epidermal
cells because of the presence of the murine T cell differentiation marker, Thy-I, expressed
by this cell population. This marker is found on all murine T lymphocytes, but usually co-
inciding with either of the two distinguishing mature T cell alloantigens, CD4 or CD8, of
which DETC display neither (107). DETC constitutively express, along with Thy-I,
CD45, asialo-GM1, a "I/o T cell receptor complexed with CD3, but no IA molecules or
surface IgG (107,71).
The vast majority ofT cells in the thymus and periphery display a polymorphic het-
erodimeric T cell receptor consisting of an a chain and a ~ chain. This receptor is linked
to a CD3 complex, which is composed of 3-5 transmembrane subunits which transmit
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activation signals from the TCR to the cell (108). A T cell of the cxJ~ variety can be fur-
ther classified by the presence of either surface CD4 or CD8 molecules, each with its own
unique MHC requirements for activation: CD4+ cells require antigen in context with
MHC class II molecules and CD8+ cells need antigen and MHC class I (83). However,
there exists a minor subset of T lymphocytes that are CD4- and CD8- which bear a
CD3-associated heterodimeric glycoprotein composed of a y and a 8 chain (46). The
antigen-MHC binding portion of the TCR, of both T cell classes, is composed of four sets
of genes: V (variable), D (diversity), J Goining) and C (constant) segments. Diversity
among T cells comes about through somatic rearrangement of these different germline-
encoded gene segments, giving the entire T cell repertoire the ability to recognize a vast
array of foreign antigens (107, 108). The overall ability of y/8 T cells to generate combi-
natorial diversity is greater than that ofa/~ T cells and this is demonstrated by TCR analy-
sis of circulating peripheral y/8 T cells, but this is not the case with resident y/8 T cell
populations in various epithelial compartments (29). And, indeed, circulating y/8 T cells
show marked variability in their TCR, but those found preferentially in these various epi-
thelium seem to be biased toward certain conserved TCR types that are site-specific. In
murine lung, y/8 T cells demonstrate a TCR bearing predominately Vy2 and V8l or V86
components (6). In gut epithelium, there is no 8 chain preference, but a strong y chain
preference toward Vy7 (54) and in the tongue and mouse female reproductive tract,
receptor chain preference is toward Vy6 and V81 (44). T cells of the murine dermis show
VyS preferences (54). Although the precise ligands of these y/8 T cells have not been elu-
cidated, researchers believe that each cell type has a conserved TCR, specific for that site,
to recognize antigens that are most likely confronted in that particular anatomic site. It
has been speculated that the importance of y/8 T cells, in general, be as a first line of
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-defense in response to infectious agents and altered or transformed self cells, initiation of
autoimmunity and downregulation of alP T cell responses (107). This speculation is pri-
marily based on the fact that increased numbers of y/o T cells have been found to infiltrate
certain disease sites involving granulomatous skin lesions (66), cutaneous melanomas,
discoid lupus erythematosus and infection sites involving Toxoplasma gondii, Listeria
monocytogenes (107, 108) and Mycobacterium tuberculosis (73).
Consistent with other yl8 populations, DETC also display extremely limited yo
pairing. Bergstresser et al have produced a number of DETC cell lines, all of which bear
identical TCR, composed of Vy3/Jy l/Cy1 and Vol /D<'52/J82/Co gene segments (108, 5, 4),
while others have shown similar results with cultured DETC lines being Vy3/V<'51 + (42, 5,
108). However, there has been some disparity, with some groups finding DETC with con-
siderable TCR heterogeneity. Possible explanations stem from different strains of mice,
variations in protocols, or differences in culture techniques. Monelonal antibody studies
were carried out by independent groups in Berkeley and Dallas in order to determine the
TCR variability of DETC in epidermal sheets and in culture. Researchers in Berkeley de-
veloped a MoAb (named F536) which was specific for all y/<'5 TCR-bearing Vy3 segments,
irrespective of the 0 chain. Using disaggregated EC and flow cytometric analysis, this
group demonstrated that over 90% of CD3+ epidermal cells were positive for the F536
MoAb (40). The MoAb developed by the Dallas group (17Dl) was also specific for Vy3+
cells, but only when those cells were associated with a V<'51 ID<'521J02-containing 5 chain.
Using whole epidermal sheets, this group determined that approximately 98% of all CD3+
epidermal cells expressed TCR that were recognized by the 17Dl MoAb (58). Interest-
ingly, the Vy3/V81 TCR characteristic of DETC is found in no other epithelial compart-
ment, peripheral blood or secondary lymphoid tissue. They have only been found in the
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-fetal thymus and are the earliest fetal thymocytes to express a CD3/TCR complex. These
Vy3/V81 thymocytes are predominant until day 17 of gestation at which time their num-
bers decline while the numbers of a/P+ cells increase (107, 108, 8).
Growth and Proliferation
Along with the presence of a T cell receptor, one attribute of the DETC that led
researchers toward classifying this cell as being of a T cell lineage was its proliferative re-
sponse to T cell mitogens. It has been shown that DETC proliferate significantly in the
presence of Concanavalin A and IL-2 and IL-2 alone after this initial activation (72, 106),
although evidence shows that activation signaling for DETC may be different than for
other types of T lymphocytes. For example, lymph node or spleen-derived T cells show
strong mitotic responses to phorbol myristate acetate (PMA) plus ionomycin, but DETC
do not and PMA plus ionomycin and IL-2 showed only marginal proliferative effects on
DETC. Also, IL-2 seems to be the primary T cell-derived growth factor for DETC while
other T cell classes respond to either fL-2 or IL-4 (110). The ease of establishing and
maintaining DETC lines as opposed to the difficulty in culturing y/8 cells from other sites
also contribute to the idea that DETC may have unusual activation requirements (107).
DETC have also been known to proliferate in response to anti-CD3 MoAb (110) and ap-
plication of certain preservatives or antioxidants in topical medications (82). It was also
found that keratinocyte-derived IL-7 could serve to maintain growth of DETC in culture
and cause proliferation in Con A stimulated cells (62). This cytokine is believed to be a
major relevant growth factor since DETC are the only cells in the epidermis to secrete
IL-2, and only after cell activation. So, it seems unlikely that IL-2 is the lone DETC
growth factor.
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-Cytotoxicity
A well-known feature of epithelial y/8 T cells is their ability to demonstrate non-
:MHC restricted cytotoxicity toward certain cellular targets and the y/8+ DETC possesses
this ability, as well. Nixon-Fulton et at have shown DETC-directed non-MHC-restricted
cytotoxicity toward the YAC-l lymphoma, a natural killer cell-sensitive target. This abil-
ity was seen only in Con A and IL-2 stimulated ceIJs and was not seen in cells that were
freshly isolated (70). This stimulation and expansion necessity for cytotoxic activity is
reminiscent of lymphokine activated killer (LAK) activity. Researchers in the same
laboratory also found that 3 long-term DETC lines, but not their supernatants, were able
to lyse the transformed keratinocyte line PAM212 and 2 transformed endothelial cell lines
in addition to a number of mouse melanoma and fibrosarcoma tumors (48). Others have
found that DETC can also lyse an ultraviolet light (UVL)-induced fibrosarcoma (74).
DETC cytotoxic activity only after stimulation, coupled with evidence that intestinal y/8 T
cells show cytotoxicity in normal, but not germ-free, animals (56) have led researchers to
believe that DETC in unperturbed epidermis must be induced to become mature lympho-
cyte killer cells. Also in support of this is the fact that DETC have mRNA for perforin, a
protein capable of forming transmembrane pores in the cell membranes of target cells (52).
Overall, the demonstration of these cytotoxic abilities toward transformed cells of the epi-
thelia support the notion that DETC playa role in immunosurveillance of the skin. That
is, DETC can recognize self cells that have been altered by a variety of means (trans-
formed, physically damaged, infected) and eliminate them before they threaten the skin's
physiologic and functional integrity.
Tolerance
Despite their role in cytotoxic immune reactions which are not MHC-restricted,
DETC also seem to playa role in normal immune responses. Contrary to the essential role
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Langerhans cells play in induction of contact hypersensitivity (CH) and delayed type hy-
persensitivity, DETC downregulate these a/f3 T cell-mediated responses since the ability
to mount a CH response has been shown, by one investigator, to be inversely proportional
to the ratio of LC to DETC in the skin (13). Hapten-conjugated DETC injected intrave-
nously or into the footpad resulted in an inability to mount an antigen-specific contact hy-
persensitivity response, while injecting hapten-derivatized normal lymphocytes or
unconjugated DETC, by these same routes, caused no impairment in mounting such a re-
sponse (107, 108). The mechanism for this tolerance may involve cytotoxic activity to-
ward normal lymphocytes (108). Furthermore, cutaneous hapten painting after UVB
radiation, a standard protocol for inducing immunologic tolerance, results in hapten-
derivatized Thy-l + cells with downregulatory abilities in draining lymph nodes (75).
These data seem to support the idea that, in addition to being effector cells in the epider-
mis, DETC may also be involved in the downregulation of cutaneous immune responses.
Antigen Recognition
To elucidate the true role of the DETC, it is first necessary to recognize the physi-
ologic ligand or ligands of this cell population. As stated previously, the TCR of DETC
are extremely restricted, with nearly all established clones being monomorphic. This TCR
homogeneity would suggest that the number of ligands that DETC can recognize is also
very restricted. To reiterate their cytotoxic ability, DETC show non-MHC-restricted lysis
toward a certain transformed keratinocyte and endothelial cell lines, as well as a number of
lymphoma, melanoma and fibrosarcoma tumors (70, 48, 74). It is believed that the DETC
expression of this invariant TCR, along with the fact that these cells are not motile, indi-
cate that DETC may not encounter a wide array of antigens, except on rare occasions.
However, they are in intimate contact with surrounding keratinocytes and may very well
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-recognize a common antigenic marker induced on damaged or transformed cells in their
microenvironment (8, 107, 108). Asamow et al have suggested that this ligand might be
mammalian heat shock proteins or stress proteins, a higWy conserved family of proteins in-
duced in many cell types by a variety of cellular insults, including heat, starvation, malig-
nant transformation and infection (4). Reports have also cited that certain y/8 T cells,
distinct from DETC, are able to respond to various species of Mycobacteria, whose anti-
gens bear striking similarity to heat shock proteins (66, 73). The current popular theory
has DETC playing their major role in cutaneous immune surveillance, where they recog-
nize heat shock proteins or other stress-induced markers on damaged epidermal cells, re-
sponding to these antigens and eliminating the stressed cells before they compromise the
physiologic integrity of the skin. This recognition of stress ligands seems not to be re-
stricted by normal polymorphic class r or II MHC molecules, but instead by more non-
polymorphic ~2-microglobulin-associated MHC-like molecules such as tissue-restricted
CD 1, Qa, or Tla molecules (117).
Epidermal Cytokines
Cytokines are low molecular weight protein substances secreted by their producer
cells in response to certain stimuli. They have much the same function as classical hor-
mones, but are classified differently, as hormones are secreted by particular endocrine or-
gans and cytokines are produced by a number of different cell types in various tissue
regions. Like hormones, though, cytokines act on their target cells after initial release
from their producer cell, where they bind by specialized surface receptors specific for that
particular cytokine. The target cell is then induced to perform a particular function, based
on the cytokine acting on it. Cytokines playa great role in coordinating numerous types
of immune responses, wound healing, cell regeneration and differentiation and they can
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also act as paracrine and autocrine growth factors. Rarely are these molecules produced
at a constant rate, but most are induced by a stimulus and they are usually present for only
a short period of time.
The discovery of the ability of epidermal cells to secrete various cytokines rein-
forced the notion that the skin was fully capable of carrying out immune functions. As
previously described, Langerhans cells, keratinocytes, as even melanocytes, are capable of
secreting cytokines. It has also been shown that DETC possess this ability, too. The larg-
est source of epidermal cytokine production has been attributed to keratinocytes, where
IL-l and TNFa may have the greatest role as keratinocyte-derived immune response
modifiers.
Studies using reverse transcriptase polymerase chain reaction have shown that
DETC possess rnRNA for a number of cytokines, including: IL-la, IL-2, IL-3, IL-6,
IL-7, TNFa, TNF~, GM-CSF, and lFNy (64, 105). They also secret keratinocyte growth
factor (KGF) and so, may playa role in promoting epidermal cell growth after injury
(107). The cytokine produced in largest quantities by DETC is probably rL-2, which
would be consistent with the large amounts produced by normal a/~ T cells. However,
while mRNA for another Thl-type cytokine, fNFy, is expressed constitutively in DETC,
IL-2 is not and is only expressed after activation, especially by Con A (64). The cytokine
repertoire of DETC seem to be of the Th 1classification. The only Th2 cytokine observed
is IL-4 and only upon secondary stimulation by both Con A and rIL-2 in short-term cul-
ture (264). Stimulation of long-term DETC lines by anti-TCR MoAb showed increased
levels of lL-2 and IFNy, but no IL-4. These results are consistent with DETC producing a
Th1 cytokine profile and would correlate with cytokine production by T cells infiltrating
the skin in a normal delayed-type hypersensitivity reaction, in which no humoral response
is present. As previously mentioned, IFNy is capable of upregulating MHC class II and
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lCAM-1 on keratinocytes, but this cytokine can also inhibit the growth ofthese cells (63).
T lymphocyte-derived IFNy can stimulate keratinocytes to secrete IL-7 (3), which in tum,
acts as a growth factor for DETC. This along with the fact that DETC secrete KGF, sug-
gest an intimate interaction between keratinocytes and DETC.
Interferon-gamma (IFNy) was first recognized over 30 years ago for its anti-viral
activity (114). Research concerning IFNy over the past decade, however, has determined
a much broader immunologic role for this cytokine, with its role an as anti-viral agent ac-
tually being quite minor. IFNy belongs to a protein family which is divided into three
classes -- interferon-a, -p and -y -- all of which are related by their ability to give protec-
tion against viral infection (30). However, IFNy is unrelated to its interferon counterparts
at both the genetic and protein levels and its antiviral activity is much lower than the other
two interferons while its ability to function as an immunomodulator far exheeds that of its
interferon counterparts (77). Although the major source of lFNy is T lymphocytes, all
cells, with the exception of erythrocytes, possess a recptor for it (30). Possibly the most
important function of this cytokine is its antiproliferative effect on Th2 murine CD4+ cells,
which makes it key in determining the type of T-helper immune function that develops
during an immune response, steering it away from the Th2 humoral response and toward
the Thl cell-mediated branch of immune effector function (30). In contrast, IL-IO inhibits
lFNy production by Th1 CD4+ T cells, inhibiting cell-mediated immune responses (68).
In effect, IFNy and IL-10 regulate the development of immune effector functions between
the Th1 cell-mediated branch and the Th2 humoral branch. Another well-known attribute
of this cytokine is its ability to upregulate MHC class I and 11 molecules on the surface of
immunologically-important cells that do not normally express them, such as mononuclear
phagocytes, endothelial cells and keratinocytes (30, 109, 51), which is an important step in
antigen presentation. IFNy is also capable of helping immature myeloid precursor cells
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differentiate into mature monocytes (30). It promotes antigen presenting abilities of
macrophages, not only by upregulating MHC class II, but also by increasing the levels of
some intracellular enzymes that may be vital to this task (47, 2) and its ability to induce ni-
tric oxide production suggests that IFNy plays an indirect role in the killing of intracellular
pathogens (30). In addition, IFNy may enhance the interact~on between macrophages and
T cells by inducing adhesion molecule expression on macrophages (35) and it plays a role
in lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNFa) by various
murine macrophage populations (25, 19).
The most important cytokine involved In T cell proliferation is Interleukin-2
(IL-2). The activity of IL-2 was first observed in cell culture supernatants of human pe-
ripheral blood lymphocytes which had been stimulated with certain T cell mitogens (93),
It was soon discovered that the activities of T cell growth factor (TCGF), thymocyte
stimulation factor (TSF), thymocyte mitogenesis factor (TMF), T cell replacing factor
(TRF) and killer helper factor (KHF) could be attributed to the same cytokine (93). The
activity of IL-2 is derived from a single protein of 15.4 kD, which provides all of its sig-
naling for T cell DNA duplication and subsequent mitosis and is produced by Th 1 CD4+' T
cells following mitogen or MHC-restricted antigen activation (93). Following this finding,
it was determined that IL-2 bound to activated T cells by way of a unique receptor, This
receptor is a heterodimer consisting of a and ~ subunits (37). The ~ subunit is constitu-
tively expressed on resting T cells, but the a subunit is only found on those T cells whose
antigen receptor has already been triggered (92). With the fully-assembled receptor con-
fined to activated cells only, T helper cells can ensure conservation of clonality of a T cell-
mediated immune response through the secretion a non-clone specific cytokine, So, in ef-
fect, responsiveness to IL-2 becomes an antigen dependent autocrine or paracrine prolif-
erative factor for those T cell-bearing functional LL-2 receptors, In addition to this
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important activity, IL-2 also plays a role in growth of B cells, natural killer (NK) and
lymphokine-activated killer (LAK) cells (93, 20), augmenting lFNy expression (76); and,
inducing IL-6 production by human monocytes (69).
Superantigens
The concept of superantigens was first brought to light in 1973, when antigens
from unmapped genetic loci able to generate intense mixed leukocyte reactions between
.MIlC-identical mice were found (1). These loci were mapped outside the MHC and were
termed minor lymphocyte stimulating (MIs) antigens. However, their functions were not
discovered for some time when in the late 1980s, two groups found the deletion of certain
T cell subsets in mice expressing MIs antigens and it was found that the recognition by the
TCR of the Mis antigens was determined by the TCR V~ domain (1). Roughly at the
same time, other groups discovered that certain bacterial toxins from various strains of
Staphylococcus aureus, responsible for causing food poisoning, possessed properties simi-
lar to those of Mis antigens. These bacterial proteins were the staphylococcal entertoxins
They are recognized by a high frequency of T cells determined by the particular type of
TCR V~ domain (45, 1), much like that of MIs antigens. Scientists were somewhat per-
plexed as to any significance in the similarities between bacterial proteins and endogenous
Mis antigens in mice until the true source of the MIs antigens was determined. A type B
retrovirus transmitted through the mammary glands of mice was found to encode a su-
perantigen within the 3' long terminal repeat of its genome (1) and was called mouse mam-
mary tumor virus (MMTV). This discovery demonstrated the first correlation between
bacterial enterotoxins and MIs antigens: both came from infectious sources.
Bacterial superantigens produced by the organism Staphylococcus aureus cause a
number of disease states in humans, including food poisoning and shock, caused by
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and B (61). Of these, the enterotoxins have been best described and characterized of all
share similar functions, but have been divided into two groups: SEA, E, and D in one and
staphylococcal enterotoxins A, B, Cl, C2, C3, D and E; toxic shock syndrome, caused by
These are highly related proteins of intermediate size thatexogenous superantigens.
toxic shock syndrome toxin; and scalded skin syndrome, caused by exfoliating toxins A
-
SEB, C1, and C3 in the other.
As previously stated, these staphylococcal superantigens activate their respective T
cell subset by intimate interaction with the TCR VI3 domain of those T cells. Recent work
has shown that these superantigens interact with an exposed region of the VI3 domain that
appears to be a l3-pleated sheet and also, the toxins engage both the TCR and MHC class
II surface antigens that are found on a number of immune cells within the body. However,
their initial target ligand is the MHC class II molecule itself (61) and its presence is essen-
tial for T cell activation by these superantigens. TCR affinity for the toxins is relatively
low and is only increased after interaction with MHC class II (33). Work with the Raji B
cell line has demonstrated a binding of SEA to certain portions of its MHC class II mark-
ers (64), but not to MHC class II negative mutant Raji B cells (67). Also, fibroblasts,
which are not normally able to bind SEA, are capable of doing so after transfection with
ID...,A-DR genes (67). It is believed that this interaction with class II MHC is not to bind
the MHC molecule to the TCR, but rather to induce a conformational change in the toxin
to increase its affinity toward the TCR VI3 region (33).
The ability of the staphylococcal superantigens to activate such a vast heterogene-
ity of T cell specificities bes in the way in which these toxins are presented to the body's
immune system. When a nominal antigen is encountered by an antigen presenting cell, it is
internalized and broken down into peptide fragments by proteolytic enzymes. The rele-
vant antigenic determinant is then complexed with newly-synthesized MHC class II
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-molecules with the entire complex finally expressed on the cell surface for presentation to
the appropriate T helper cell (49). The MHC class II molecule is made up of a membrane-
bound alpha and beta chain, each comprised of two extracellular domains (60). The most
significant structure of this molecule bears two near-parallel a-helical structures that form
a cleft which is supported by an extended ~-pleated sheet (60). This forms the peptide
binding groove where an antigenic peptide fragment is displayed for presentation. En-
countering the antigenic epitope, along with the self MHC markers, provide the first acti-
vating signals for the T cell. In the case of superantigens, however, this entire process is
much different. First, these proteins do not need to be processed by the antigen presenting
cell and proteolytic fragments of these toxins will not activate T cells at all (34). Also,
they are able to associate with various MHC class II alleles and isotypes from a number of
different mammalian species (33). Another unique feature of superantigen presentation is
the fact that they do not occupy the peptide binding groove of the MHC class II molecule
when recognition by the T cell takes place. This has been seen by studies showing that
SEB association with class II MHC molecules does not inhibit subsequent antigen presen-
tation of hen egg lysozyme peptides to T cell clones (27) and further supported when it
was found that the binding ofTSST-l did not prevent the binding ofa HLA-DR-restricted
peptide (50).
Although the mechanisms by which a/~ CD4+ T cells are activated by staphylo-
coccal superantigens has been well documented, the means by which these toxins interact
with ylB T cells is less well understood. Recent work has shown, however, that ylB T cells
are capable of proliferating in response to staphylococcal enterotoxins and also show cyto-
toxic activity, possibly by more than one pathway. Studies using human ylB T cells have
demonstrated an ability for these cells to show proliferation (32, 94) in the presence of,
and cytotoxicity toward, SEA-coated targets, restricted to those cells bearing the Vy9
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-receptor and only in the presence of MHC class II positive accessory cells. This type of
response usually responds to only SEA, unlike alB T cells which are known to respond to
a wide variety of staphylococcal enterotoxins (87). Other findings have also shown that
peripheral blood Vy9+ T cells were capable of lysing SEA-coated target cells. Interest-
ingly, some of these cells possessed the IgG FcRIII and were capable of mediating
antibody-dependent cellular cytotoxicity (ADCC) against SEA-coated target cells, but
only in the presence of certain human sera, When this sera was depleted of anti-SEA anti-
bodies, cytotoxicity of these T cells was inhibited (86). These works and others (79, 59)
seem to indicate that responses of ylB T cells to SEA are restricted to those cells bearing
the Vy9 chain, but others have indicated that this may not necessarily be the case (32, 94).
A certain Vy9 subset was shown to expand by in vitro culture with a I to 3 kD protease-
resistant fraction from a mycobacterial lysate at a degree of lout of every 6 cells. This re-
sponse was dependent upon MHC class II+ presenting cells and overall, demonstrates a
superantigenic capacity of certain mycobacterial ligands (79). This, along with the fact
that Vy9+ cells are the most prevalent ylB T cell in the periphery suggest that these cells
may be significant in fighting off bacterial infections.
In these processes, the response to SEA-coated target cells requires accessory or
presenting cells positive for MHC class II as evidenced by inhibition of cytotoxicity or
proliferation by addition of anti-MHC class Il antibodies or removing accessory cells (86,
87, 79, 94, 59). However, ylB T cells obtained from peripheral blood and cerebrospinal
fluid of patients with multiple sclerosis were able to proliferate in response to, and show
cytotoxic activity toward, B cells pulsed with either SEA, SEB, or TSST, all in a non-
MHC-restricted fashion (99). Most of what is known about the activity of ylB T cells to-
ward staphylococcal enterotoxins has been derived from the human system. Little is
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known about this relationship in mice and nothing at the present time is known about su-
perantigen response to DETC.
28
CHAPTER 2
MATERIALS AND METHODS
Animals
All animals used in this study were 6-to-8 week old Balb/c female mice obtained
from Charles River (Wilmingtion, MA). These mice were maintained in a licensed facility
at Oklahoma State University.
Toxins
Staphylococcal Enterotoxin A (SEA, Toxin Technologies, Sarasota, FL) was ap-
plied to dorsal trunk skin and epidermal skin sections of Balb/c mice in DETC depletion
studies. SEA was also added to whole epidermal cell cultures to induce production of cy-
tokines. Biotinylated SEA (Toxin Technologies) was used in the immunofluorescent SEA
binding studies of epidermal cell suspensions.
Media and Solutions
Phosphate-buffered saline (PBS, 0.15 M) was used to make up solutions of trypsin
(type II from porcine pancreas, Sigma Chemical Company, S1. Louis, MO), deoxyribonu-
c1ease I (DNase I, from bovine pancreas, Sigma), antibody dilutions, resuspension of Iy-
ophilized SEA and hydration of murine dorsal and ventral skin sheets. One liter of 0.15 M
PBS contains 1.15 g. dibasic anhydrous sodium phosphate (N~HP04' Fisher), 8.0 g. rea-
gent grade sodium chloride (NaCl), 0.2 g. potassium chloride (KCl, Fisher) in deionized
water and pH adjusted to 7.2 before autoclave sterilization for 20 minutes at IS psi. PBS
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with Tween 20 (Sigma) was used in washing steps in immunohistochemical staining of
epidermal skin sections. PBS with 1% BSA (Fisher) and 0.05% NaN} (Sigma) was used
in the immunofluorescent staining of epidermal cells.
Dimethyl sulfoxide (DMSO, Sigma) was used to resuspend SEA for use in DETC
depletion studies or as an SEA control in the same experiments,
In immunohistochemical staining of DETC, skin sections were floated on 2 M so-
dium bromide (NaBr, Fisher Chemical) to separate the epidermis from derrnis.
Cell washings in the generation of epidermal cell suspensions were performed in
Cellgro RPM! 1640 tissue culture media (Fisher) supplemented with 5% fetal bovine se-
rum (FBS, Atlanta Biologicals, Norcross, GA), 100 D/ml penicillin (Sigma), 0.1 mg/ml
streptomycin (Sigma), 0.1 roM MEM non-essential amino acids (Sigma), and 0.1 mM so-
dium pyruvate (Sigma). Epidennal cells were cultured in the same media with the addition
of 2 mM L-glutamine (Sigma), 5mgIL gentamycin (Sigma) and 15% FBS.
Antibodies and Conj ugates
Purified monoclonal anti-mouse CD90 (Thy-I.2, Pharmingen, San Diego, CA) and
monoclonal anti-mouse y/8 TCR (Pharmingen) were used as primary antibody in the im-
munohistochemical staining of DETC in fresh epidermal skin sections. Both of these
monoclonal antibodies (MAb) are of the IgG isotype. Phycoerythrin (PE)-labelled anti-
mouse CD90.2 (Pharmingen) was used in immunofluorescent binding studies of epidermal
cell suspensions, Fluorescein isothiocyanate (FITC)-conjugated avidin (Accurate Anti-
bodies, Westbury, NY) was used to verify biotinylated SEA binding to epidermal cells in
the same studies.
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Epidermal Cell Suspensions
Body trunk hair was removed from mice by clippers and a depilatory before being
sacrificed in an ether chamber, Dorsal and ventral body trunk skin was surgically removed
and placed in a clean 100 mm x 15 mm Petri dish (Fisher), keeping skin rolled up to pre-
vent drying out. Ears were removed, split with forceps and placed epidermis-side up on a
fresh solution of 0,25% trypsin. The tail was cut off, split down one side by a scalpel and
skin removed and also placed epidermis-side up on the trypsin solution. Dorsal and ven-
tral trunk skin were then laid epidermis-side down in the clean Petri dish and the subcuta-
neous layer scraped away by a scalpel. After cutting the dorsal skin into two equal parts,
the sections were placed epidemis-side up on the trypsin. Body skin, ears, and tail were
then incubated for one hour at 37° C in the presence of 5% CO2, Following incubation,
skin and ear sections were transferred, epidermis-side down, to a 100 mm x 20 mm deep
well Petri dish (Fisher). Immediately after removing the dermal layer, all sections were
immersed in a 0.05% DNase I solution and rubbed with a blunt-tip glass rod to bring cells
into suspension. The epidermal layer of the tail was separated from its dermal layer and
rubbed with the glass rod. Three to four equal volumes of RPMI 1640 with 5% FBS were
added to the suspension and the suspension aspirated approximately 20 times with a 60cc
syringe (Fisher), then filtered through a Falcon 70 jlm nylon mesh cell strainer (Becton
Dickinson, Lincoln Park, NJ) into a Sarstedt 50 ml test tube (Sarstedt, Princeton, NJ).
The cells were then pelleted in a Damon CRU-5000 centrifuge (IEC, Needham Heights,
MA) for 8 minutes at 4° C and washed three times to remove all traces of DNase 1. Cells
were resuspended in 10 ml of tissue culture media and quantitated by trypan blue (Sigma)
exclusion on a hemacytometer and adjusted to the desired concentration.
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Immunohistochemical Staining of Epidermal Skin Sections
Hair was removed from the dorsal side of a female Balb/c mouse and the mouse
then sacrificed in an ether chamber. Dorsal trunk skin was surgically removed and placed
epidermal-side down in a clean Petri dish and kept hydrated with culture media or PBS.
Skin was then cut into a desired number of 0.7 cm2 sections and each placed in separate
wells of a Falcon 24-well flat-bottom tissue culture plate (Becton Dickinson, Lincoln Park,
NJ) containing three 1.3 em antibiotic filter discs and 600 1..11 culture media. Subsequently,
25 III of SEA or DMSO were applied to the skin sections. Sections were incubated for 48
hours at 37° C in the presence of 5% CO2. After incubation, skin was floated on 2 M so-
dium bromide and incubated for] hour at 37° C with 5% CO2 . In a Petri dish of PBS, epi-
dermis was removed from the dermis by scraping with a scalpel and then transferred to a
new 24-well plate. Epidermal sections were rinsed with PBS and fixed in cacodylate-
buffered formaldehyde for 15 minutes at 4° C. Hydrogen peroxide was added and skin
sections incubated for 30 minutes on a plate shaker, washed three times with PBS-Tween
and incubated for another 20 minutes with fresh hydrogen peroxide. Sections were
washed again and blocked with 10% FBS for 20 minutes on a plate shaker at room tem-
perature. After washing, epidermal sections were incubated overnight at 4° C with anti-
mouse Thy-1.2 or anti-mouse riB TCR. After incubation with the 1° Ab, sections were
washed and incubated overnight at 4° C with biotinylated anti-mouse IgG from a Vecta-
stain Elite Mouse IgG ABC kit (Vector Laboratories, Burlingame, CA). After washing,
skin was incubated with Vectastain ABC reagent at room temperature for IS minutes on a
plate shaker. During this incubation, substrate solution was prepared from a Vector ABC
peroxidase substrate kit or Vector VIP peroxidase kit (Vector), depending on the color
desired. After the final washing, substrate solution was added and sections incubated for
5-15 minutes at room temperature until the desired color was achieved. Sections were
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then mounted in glycerol on microscope slides and stained cells quantified with the aid of a
epifluorescent microscope.
Double Immunofluorescent Staining of Epidermal Cells
An epidermal cell suspension was prepared from 1 Balb/c female mouse and resus-
pended in PBS-BSA-NaN3 at a concentration of 1 x 10
1 cells per mt. One ml of the cell
suspension was placed in a 15 m] test tube as the control and 1 ml placed in another test
tube as the experimental group. Biotinylated-SEA (Toxin Technologies) was added to the
experimental group at a final concentration of 10 'Ilg/ml, while the control group received
an equal amount of PBS. The tubes were placed on a tube rotor and rotated slowly for 2
hours at 4° C. Cells were subsequently washed twice with PBS and then fixed in
cacodylate-buffered formaldehyde for IS minutes at room temperature on the tube rotor.
The cells were washed again and transferred to clean microcentrifuge tubes at a
concentration of I x 101 cells per ml, spun at Jow speed (8500 rpm) in a table top BHG
Z230 M high speed centrifuge (BHG & Co, Germany) for 15 seconds and the supernatant
discarded. Cells were suspended in both 50 ~Li of avidin-FJTC at I :50 dilution in
PBS-BSA-NaN3 and 50 III ofPE-labelled anti-CD90.2 at 1.20 dilution in PBS-BSA-NaN1
and incubated on a tube rotor for 30 minutes at 37° C. CeHs were washed twice and each
pellet resuspended in 50 III of glycerol, mounted on microscope slides and percentages of
labeled cells enumerated.
Cytokine Production by Epidermal Cells After SEA Application
An epidermal cell suspension was obtained, as previously described, from 1 Balb/c
female mouse and cells resuspended at a concentration of 1 x 106 cells/mI. After the
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correct cell concentration was obtained, I rnl of the cell suspension was then plated out in
a Falcon 24-well tissue culture plate (Fisher), in duplicate, for each of the time points for
12 hours, 24 hrs, and 48 hrs. SEA was then added to each experimental well at a final
concentration of 5 Ilg/ml (50 Ill) and 50 III of PBS added to each controt group. Super-
natants for each group were taken at their respective time points and stored at _800 C until
all points were taken. Once all supernatants were collected, 1.6 ml of each group was
loaded into a 4 kD NanoSpin Plus microconcentrator (Gelman Sciences, Ann Arbor, MI)
previously blocked overnight with a 1% 8SA solution. Supernatants were then spun in a
Sorvall RC 58 Plus centrifuge (Du Pont, Newtown, CT) at 6800 g for 2 1/2 hours at 4° C
to obtain 4x concentrated samples. Concentrated supernatants were then analyzed for lev-
els of IFNy and IL-2 production (Genzyme, Cambridge, MA). Supernatants were also
tested for IL-I0 levels by ELISA (Genzyme), but were assayed directly from culture and
were not concentrated.
Interferon-y ELISA
IFNy from epidermal cell culture supernatants was assayed by Intertest-y Mouse
Interferon-y ELISA kit (Genzyme). This assay employed the multiple antibody sandwich
principle, where a 96-well microtiter plate was precoated with monoclonal anti-mouse
IFNy. Tissue culture samples with the suspected IFNy were added to the necessary num-
ber of wells in 100 III volumes and incubated overnight at 4° C to allow IFNy to bind to
anti-mouse IFNy mAb. Wells were washed four times with the provided wash buffer and
100 III of biotinylated polyclonal anti-mouse IFNy was added to each well and again, incu-
bated overnight at 40 C. Washing was performed as before and horseradish peroxidase-
conjugated streptavidin was added and incubated for two hours at room temperature to al-
low binding to the biotin. Wells were washed one final time and substrate reagent of
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tetramethylbenzidine and buffered hydrogen peroxide added, then the subsequent enzyme-
substrate reaction allowed to proceed for 15 minutes at room temperature. This reaction
was stopped by the addition of 100 III of 1 M sulfuric acid stop solution and the plate
read in a Vmax kinetic microplate reader (Molecular Devices Corp., Palo Alto, CA) at
450 nm.
InterJeukin-2 ELISA
Epidermal cell culture supernatants were assayed for IL-2 by the Intertest-2X
Mouse Interleukin-2 ELISA kit (Genzyrne). Tissue culture supernatants and IL-2 stan-
dards were added to wells precoated with monoclonal anti-mouse IL-2 and incubated
overnight at 4° C. Addition ofbiotinylated polyclonal anti-mouse IL-2 followed and after
overnight incubation at 4° C, streptavidin-peroxidase for 2 hours at room temperature. Fi-
nally, tetramethylbenzidine in buffered hydrogen peroxide substrate reagent was added for
10 minutes, the reaction stopped by 1 M sulfuric acid stop solution and read by ELlSA
plate reader at 450 nm. All steps involved 100 Jll volumes and wells were washed 4 times
with the provided wash solution between each incubation period.
Interleukin-t oELISA
Epidermal cell culture supernatants were assayed for IL-IO by the Jntertest-IOX
Mouse Interleukin-l 0 ELISA kit (Genzyme). Tissue culture supernatants and IL-I 0 stan-
dards were added to wells precoated with monoclonal anti-mouse IL-IO and incubated
overnight at 4° C. Addition of biotinylated polyclonal anti-mouse IL-l 0 followed and after
overnight incubation at 4° C, streptavidin-horseradish peroxidase was added for 2 hours at
room temperature. Finally, tetramethylbenzidine in buffered hydrogen peroxide substrate
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reagent was added for 15 minutes, the reaction stopped by 1 M sulfuric acid stop solution
and read by ELISA plate reader at 450 nm. All steps involved 50 III volumes and wells
were washed 3 times with the provided wash solution between each incubation period.
Summary
The purpose of the present study was to first determine if Staphylococcal entero-
toxin A (SEA) could induce dendritic epidermal T cell (DETC) depletion from murine epi-
dermis as has been previously shown with Langerhans cells (80). The second objective
was to examine secretion of IFNy and IL-2 from murine epidermal cells after stimul.ation
with SEA. It has been shown that SEA is able to induce elevated production ofTL-l a and
to a lesser extent, TNFa in epidermal cell suspensions (91). Also of interest was to deter-
mine if SEA was actually bound by the DETC itself. The results of these studies sought
out a better understanding of the role of the DETC and how it may interact with other
cells in the cutaneous immune response.
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CHAPTER 3
RESULTS
The purpose of this study was to determine the physiological effects, if any, of
Staphylococcal enterotoxin A (SEA) on dendritic epidermal T cells (DETC) found in
murine epidermis and in doing so, help to elucidate the function of DETC within the epi-
dermis. It has already been known that SEA can cause significant depletion of Langerhans
celIs (LC) from the epidermis (80) and is also capable of inducing non-T celI cytokine se-
cretion from murine epidermal celI suspensions (91), The objective of this study was to
determine if SEA could have similar effects on DETC. All data obtained in each
investigation was pooled from three separate experiments and expressed as the mean ±the
standard error of the mean for each set of data. The student t-test was also performed to
determine statistical significance between control and experimental groups.
Effects of SEA on DETC Depletion
As previously stated, SEA is very effective at causing Langerhans cell depletion
from the epidermis (80). Other evidence from the same lab has suggested that these cells
do, in fact, migrate out of the epidermis and through the underlying dermis and subcutane-
ous layers (Kuschell and Burnham, unpublished results), as IA+ cells were detected in
these regions, in a time-dependent manner, following SEA treating of the skin. To deter-
mine whether or not DETC possess this same ability upon SEA stimulation, dorsal skin
sections were treated with 100J.l.g/ml of SEA, incubated for 48 hours at 3T C in the pres-
ence of 5% CO2 and then stained for the rio TCR surface antigen by peroxidase and Vec-
tor VIP substrate. As Figure I shows, SEA application on murine epidermis does not
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-deplete DETC. The original procedure with Langerhans cells was repeated to verify the
stimulatory properties of the SEA and the results shown side-by-side with the DETC stud-
ies. Statistics performed, by way of the student t-test, verified that the differences in the
results from the control group and SEA group were not statistically significant. The y/B
TCR monoclonal antibody used in the immunohistochemical staining of the epidermal tis-
sue sections was chosen due to the fact that although, on extremely rare occasions, an
a/B+ T cell will migrate up into the epidermis, the DETC is the only cell in that compart-
ment possessing a T cell receptor of the y/B variety (16). To corroborate the results given
in this first experiment, the study was repeated, but a mouse anti-Thy-I.2 monoclonal anti-
body was used this time to visualize the DETC. Langerhans cells were not stained for in
this experiment, since the SEA was proved to have been effective against it in the first de-
pletion experiment utilizing mouse anti-y/8 TCR as the DETC marker. The results from
this follow-up experiment are displayed in Figure 2. As the figure shows, there is no de-
pletion of Thy-l + cells from the epidermis after SEA application to the skin. Again, the
student t-test was utilized and it was determined that the numerical differences between
the control and experimental groups was not statistically significant. The overall average
numbers of cells per mm2 were slightly lower in this instance than in the results from Fig-
ure I and may be caused by a difference in receptor density between the y/o TCR surface
antigen and Thy-I, but was not verified. The cell number differences between the two ex-
periments was not however, statistically significant as evidenced by the student t-test.
Although it was shown that DETC were not depleted from sections of murine skin
in vitro, an experiment had not been attempted to ascertain the possibility that these cells
would respond differently to SEA in vivo, and so, see reduced numbers. On the other
hand, certain preservatives used in topical medications and foods possessed the ability to
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Figure 1. Effects of SEA on the depletion of Langerhans cells and DETC from
murine epidennis. The values shown represent the mean ± SEM
determined by pooling the data from three separate experiments.
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Figure 2. Effects of Thy-l.2 positive DETC depletion from murine epidermis
following SEA application. The values shown represent the mean ±
SEM determined by pooling the data from three separate experiments.
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-increase the number of resident DETC in vivo (82), and although SEA is not structurally
similar to any of those chemical compounds, the possibility that SEA may actually increase
the number of DETC had not been explored. To establish the possibility of a significantly
increased or decreased number of DETC upon in vivo application of SEA, 25 ~l of SEA
at a concentration of 100 Ilglml was painted onto bare dorsal trunk skin of a female Balb/c
mouse once per day over a period of four days. The mouse was sacrificed, the treated
skin cut into sections and stained with mouse anti-Thy-1.2 monoclonal antibody, as previ-
ously described. As the results show in Figure 3, the number of DETC present. in SEA
and control groups was comparable. However, there was a sLightly more noticeable de-
cline in the SEA group's numbers, but in comparing the two groups by the student t-test,
differences were determined to not be statistically significant.
Therefore, unlike Langerhans cells, DETC do not appear to migrate, or are not de-
pleted, from murine epidermis following stimulation with SEA. These results may not be
surprising, however, since the role played by the LC is that of premier antigen presenting
cell of the epidermis. Currently, the functional role of the DETC is not known and their
ability to interact with or respond to superantigen has not been previously explored.
These data demonstrate that SEA shows no significant ability to affect the number of
Thy-l.2+ or y/8 TCR+ cells in murine epidermis.
Binding of SEA to Thy-l Positive Epidermal Cells
One of the significant questions to be asked in determining the ability of DETC to
playa role in SEA-induced immune responses addresses whether or not DETC have re-
ceptors for the toxin itself It has been shown that in Langerhans cell migration caused by
SEA stimulation, IL-l a and to a lesser extent, TNFa may be the primary signals that initi-
ate this migratory response (90). Although the application of SEA to mouse skin
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Figure 3. Effects of DETC depletion from murine epidennis after in vivo
application of SEA. The values shown represent the mean ± SEM
detennined by pooling the data from three separate experiments.
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-induces LC migration from the epidermis, it is still not known whether or not the toxin ac-
tually does bind to the cell,
To detennine the binding affinity ofDETC toward SEA, whole epidermal cell sus-
pensions were incubated with biotinylated SEA, fixed in cacodylate-buffered formaldehyde
and incubated with avidin-FITC and phycoerythrin-conjugated mouse anti-Thy-l. 2 mono-
clonal antibody. Cells were then mounted on microscope slides and fluorescent cells enu-
merated at 400x total magnification on a fluorescent microscope. The percentages of
both single- and double-labelled cells are shown in Table 1, Those cells which bound SEA
were determined to be those that displayed a bright optic yellow color under the appropri-
ate filter. Numerous cells portrayed a dull, faint yellow color, but only those cells giving
off a color many magnitudes higher were counted as positive. PE-Iabelled cells excited
under the appropriate filter as a brilliant red. Again, a number of cells gave off a faint red-
dish color, but only those few of a great intensity were recorded as being positive. Also,
when both FITC- and PE-positive cells were counted for a field of view, the number of
double-positive cells was determined. As Table 1 shows, no cells were ever found to be
both FITC- and PE-positive. Interestingly, out of the many cells that gave a somewhat
background or low level of yellow color, no cell found to be Thy-1.2+ displayed any level
of this color yellow color, whatsoever. Hence, there were no cells that were determined
to bind SEA that were also positive for the DETC surface marker, Thy-1.2. In both
groups, that which was incubated with SEA and that which was incubated without, the
percentage of total epidermal cells expressing the Thy-l surface marker was approxi-
mately 1%, which was consistent with the average number of DETC found in the epider-
mis (la, 111). Those cells binding SEA were not stained for any other surface markers,
so whether they were Langerhans cells or keratinocytes remained undetermined.
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-Table 1
Binding of SEA to Thy-l+ epidermal cells as shown
by immunoflourescence microscopy
Average Percentage of Percentage of Percentage of
number of cells FITC-positive PE-positive FITC and PE
per trial cells cells positive cells
Control Group 1,184.67 0.06 + .04 1.12+.18 0
(No SEA)
Experimental 1,738.33 0.56 + .09 0.94 + .14 0
Group
(SEA added)
* Biotinylated SEA used and captured with avidin-FITC (floursceinisothiocyanate)
added
* PE (phycoerythrin)-Iabeled anti-mouse Thy-l.2 monoclonal antibody
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-IFNy Secretion by Whole Epidermal Cell Suspensions
Previous studies have shown that epidermal cell subpopulations are capable of cy-
tokine secretion upon stimulation with SEA (91). To detennine if epidermal cells could
secrete levels of IFNy, whole epidermal cell suspensions were obtained at a concentration
of 1 x 106 cells/ml and plated out in a 24-well tissue culture plate at 1 ml per well. The ex-
periment was carried out over 48 hours, with 12, 24, and 48 hour time points. SEA was
given to each well at a final concentration of 5 Ilglml for the experimental group, and PB S
only for the control, and tissue culture supernatants harvested at the appropriate time
point. After supernatants had been collected at each time point, IFNy levels were analyzed
for both groups by ELISA. The experiment was repeated three times and the results aver-
aged. These results are displayed in Figure 4. As the figure shows, levels of IFNy, in
pglml, increased over the course of the 48 hour period, but the control groups increased,
as well. This was consistent throughout repeated experiments. With the fear of possible
lipopolysaccharide (LPS) levels in the media, due to bacterial contamination, stimulating
the epidermal cells, the experiment was repeated with a certified pyrogen-free media, but
levels of IFNy in control groups were not diminished (results not shown). Again, the ex-
periment was repeated, but after the normal RPMI media, used for cell culture, was run
over an endotoxin-depleting column in another attempt to remove possible pyrogen con-
tamination. Again, IFNy control levels remained high (results not shown).
Although both SEA and control groups were increased in their levels of IFNy pro-
duction over the course of the 48 hours of the experiment, the levels in the control group
did tail off somewhat at 24 hours and did remain lower than the levels recorded from the
SEA group. However, results from analysis of the data by the student t-test showed that
the differences between the SEA and the control groups were not statistically significant.
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Figure 4. SEA-induced IFNyproduction by murine epidennal cells. The values
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the data from three separate experiments.
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-Since DETC are the only cell in the epidermis capable of secreting IFNy (64, 105), it was
determined that in the culture conditions of the experiment, DETC are capable of secret-
ing increasing levels of IFNy over a period of time, at least for 48 hours. However, it was
not determined what the nature of the stimulating factor was since IFNy levels consistently
rose in the control group, which was not treated with SEA, as well as the SEA group
itself
IL-2 Secretion by Whole Epidermal Cell Suspensions
The second T cell cytokine examined for its ability to be produced by epidermal
cells after SEA stimulation was IL-2. As with the experiments set up to look for levels of
IFNy production, epidermal cell suspensions were generated, plated out in a 24-well tissue
culture plate, SEA added to one group, and tissue culture supernatants collected at three
time points over a 48 hour period. Finally, supernatants were examined for levels of IL-2
by ELISA and the results displayed in Figure 5. The results show that small amounts of
IL-2 are produced in increasing fashion over time, although those levels did not quite
reach the quantity of IFNy produced in the prior experiment. These experiments were
also performed three times and the results from each time point averaged. The figure
shows, much like the ELISA studies on IFNy, that IL-2 levels increase over time in both
the SEA and the control groups. Experiments using certified commercial pyrogen-free
media and endotoxin-depleted media were performed, but the control levels observed re-
mained similar to those previously observed (results not shown).
Although IL-2 levels in the control group increased with the SEA levels, they too,
remained lower than the pg/mllevels expressed by the SEA group after 24 hours onward,
The student t-test was performed, but the differences between the two groups was not
shown to be statistically significant.
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-Like IFNy, IL-2 can only be produced by a single epidermal cell type -- the DETC
-- and the results show that IL-2 can be produced by DETC over a 48 hour period in cul-
ture, but the source of stimulation remains to be elucidated.
IL-10 Secretion by Whole Epidermal Cell Suspensions
In addition to IFNy and IL-2, whole epidermal cell suspensions were exposed to 5
~g/rnl levels of SEA over a 48 hour period and assayed for IL-IO by ELISA In three
separate experiments, it was determined that there were negligible levels of IL-IO pro-
duced in whole epidermal cell suspensions throughout the duration of the 48 hours of the
experiment. These results were consistent in both experimental and control groups. As
Figures 6 and 7 demonstrate, there is a propensity for the Th 1 cytokine profile in epider-
mal cell suspensions in these studies, as shown by the accumulation of IFNy and IL-2,
while a shift away from the Th2 profile was demonstrated by a lack of IL- I0 production.
Summary
The results from the investigations undertaken in this study have determined a
number of things about the interaction between dendritic epidermal T cells (DETC) and
the bacterial superantigen, Staphylococcal enterotoxin A (SEA). First, unlike Langerhans
cells (LC), DETC are not depleted from the epidermis after exposure to SEA When SEA
was painted on mouse skin and stained for DETC cell surface markers Thy-l.2 and ylb T
cell receptor, there was not any DETC depletion. .Even In vivo experiments where daily
painting of SEA on a live mouse was performed for four consecutive days, there was no
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-statistically significant reduction in the number of Thy-l.2 positive cells from the epider-
mis. Double fluorescent staining experiments demonstrated that no DETC, detected by
phycoerythrin-labelled mouse anti-Thy-1.2 monoclonal antibody, were able to bind
biotinylated SEA, which was detected by conjugating with avidin-florosceinisothiocyanate
(FITC). No cell was detected for simultaneous binding by both florescent markers. In
whole epidermal cell suspensions, DETC were able to produce IFNy and IL-2, but no
IL-l 0, over a 48 hour period after initial stimulation by SEA. Although pg/ml levels of
IFNy and IL-2 were relatively low, both increased over time. However, both SEA and
control groups increased with the progression of the experiment. The cytokine levels from
the control groups of both IFNy and IL-2 remained lower than its corresponding SEA
group, but they were still increased and the differences determined to be statistically insig-
nificant. Experiments were performed to determine the possibility of cell stimulation by
bacterial lipopolysaccharide contamination in the tissue culture media, but results proved
that this was probably not the cause of the cytokine production in the control groups of
both experiments. The true cause of this stimulation remains unknown.
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CHAPTER 4
DISCUSSION
The dendritic epidennal T cell (DETC) exists as a resident dendritic cell in murine
epidermis which constitutes a part of the cutaneous immune response system in mice. It
has been a curious phenomenon that this cell population should exist as a resident epider-
mal cell bearing a ylo T cell receptor which is found in no other mammal than mice. First
reported in 1983 (10, Ill), it was not until the discovery of the T cell receptor (53) on the
DETC that researchers began to ask what role, if any, this cell played in the cutaneous im-
mune response. A number of characteristics have been attributed to DETC, both in vivo
and in vitro, since their discovery, but their true physiologic role remains unknown. Since
this cell has only been found in the murine system, the true immunologic role of DETC,
and especially how DETC interact with the other cellular components of the skin immune
system, is ofgreat interest.
Previous studies using bacterial superantigens -- specifically, Staphylococcal enter-
otoxins -- have been effective in elucidating epidermal Langerhans cell cytokine produc-
tion, migration and possible mechanisms for how this migration is initiated (80, 90, 91). It
is known that these superantigens have a great capacity to stimulate peripheral a/~ T lym-
phocytes by their novel interaction with only the V~ domain of the a/~ TCR. Thus, much
of the molecular mechanisms behind this interaction are now understood. However, su-
perantigen interaction with r/8 T cells is not well understood and studies in this area have
been fewer in number than those of their a/~ counterparts. The work that has been done
in the area of rio T celJ-superantigen interaction has been done in the human system and
no studies to date have attempted to determine what effects Staphylococcal superantigens
have on DETC.
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The purpose of this study was to use Staphylococcal enterotoxin A (SEA) to alter
the physiology of DETC in an attempt to better understand their physiologic function in
the skin. Moreover, we wanted to use superantigens as a model for looking at how DETC
may interact with the other immune cells within the epidermis, namely Langerhans cells
and keratinocytes, and what their possible role may be in a cutaneous immune response.
Being the premier antigen-presenting cell in the skin, the Langerhans cell (LC)
must pick up foreign antigen that has compromised the skin's outer layers and present it to
the proper T cell clone to induce a contact hypersensitivity response. To accomplish this,
they must travel out of their resident environment and migrate to draining lymph nodes
where antigen presentation can take place. Previous studies have shown that staphylococ-
cal enterotoxins are capable of inducing a migratory response in LC after toxin painting on
dorsal trunk skin of Balblc mice (80), which was similar to results obtained after UYB ex-
posure of murine epidermis (18). In these studies, staphylococcal enterotoxin A exhibited
the greatest effect on LC depletion. Although UVB-induced depletion of LC shows simi-
lar effects as that of SEA-induced LC depletion, DETC are not depleted from the skin af-
ter UVB exposure, but hapten painting on mouse skin, followed by UV exposure resulted
in a number of hapten-conjugated cells in draining lymph nodes that were la- but Thy-l +
(75). The same toxin was used in this study to determine ifDETC could be depleted from
murine epidermis in a manner similar to LC. After SEA painting on murine skin sections
and immunohistochemical staining for ylo TCR surface antigen, it was demonstrated that,
contrary to LC, DETC were not depleted in any way from the epidermis by this toxin.
These results were confirmed by repeating the experiment with Thy-l as the DETC stain-
ing marker. In this second experiment, there were no significant differences between the
number of DETC in the group that received SEA and the control group that received only
DMSO, but there was a higher number of stained cells, overall, in the groups that were
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stained after capture by the anti-y/o TCR antibody. This could be the result of a slight dif-
ference in the number of T cell receptor antigens on the surface of DETC as opposed to
that of the Thy-l marker. It is also possible that the antibody for the y/o T cell receptor
had a slightly higher affinity for its epitope and so, was able to bind more quickly, or to a
higher degree within the time frame of the antibody incubation step. Regardless, both of
these markers are highly selective for DETC in the epidermal environment and the DETC
is the only cell in this region to be found with a y/o TCR. There are occasional aI~+
CD8+ cells that make their way into the epidermal layers that might be counted along with
DETC in these experiments, as they are also Thy-l +. However, this would be a highly un-
likely source contributing to the difference in DETC numbers between the two experi-
ments, since it was the group stained for y/o TCR that displayed the higher numbers, not
those stained for Thy-I. In the in vivo study, our goal was to determine if SEA had the
capacity to reduce the number of DETC in the living system or conversely, to determine if
SEA could cause a proliferation of DETG It has been suggested that certain topical sub-
stances applied to mouse skin could cause an increase in the population density of resident
DETC (82). Although these substances are structurally unrelated to SEA, they do behave
somewhat like pertussis toxin, which possesses the capacity for polyclonal T cell activa-
tion. All of the results from this previous study were evident within five days, which was
the basis for the five day time period of our in vivo DETC depletion study. The results
from this experiment show that the density of Thy-I+ DETC in murine epidermis after
SEA application in vivo remains consistent with those results obtained from the same ex-
periments conducted in vitro. However, Figure 3 shows that the number of DETC per
mm2 in the in vivo SEA group was slightly lower than that of the control group. The stu-
dent t-test was performed on these data and determined that the differences between the
two groups were not statistically significant. It is possible though, that the continual
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-application over the four day period was able to cause an affect in the cells that a single
dose was not able to induce. The numerical differences between the groups might be re-
duced if the number of trials was increased, as standard deviation usually decreases with
the increase in the number of data sets.
Overall, the results have shown that unlike LC, DETC numbers are not reduced in
the skin by SEA application, but this may be consistent with the role of this cell. Al-
though, the true role of the DETC has not been elucidated, one popular theory is that
DETC are highly involved in the process of immune surveillence within the epidermis (8,
107, 108) as evidenced by their ability to show non-MHC restricted cytotoxicity toward a
number of tumor targets (70, 48, 74). Cells in the epidermis that were transformed would
display altered self antigens on their surface and damaged cells may produce certain stress
signals that the DETC would react to so as to rid the body of these cells before they com-
promised the immunologic integrity of the animal. This would be further supported by the
limited diversity of the T cell receptor of DETC, implying that this cell recognizes a single
antigen or highly conserved set of antigens. Since this cell is sessile, this antigen would
have to be found in a much higher degree in the skin than in the periphery for DETC to be
effective in playing out its physiologic role. In light of this, immune surveillence would be
a role consistent with the properties of DETC. It is possible that DETC are not stimulated
by SEA and even if this were, in fact, the case, migration out of the skin may not be how
DETC would react to such a stimulus. With the highly conserved TCR of DETC, it may
be very likely that SEA is not an antigen that it recognizes.
While LC modulation by SEA has demonstrated a migratory ability in tissue sec-
tions, it has also proven effective in cytokine induction of epidermal cells. Previous stud-
ies have indicated increased levels of IL-l a and TNFa in epidermal cell suspensions that
have been stimulated by SEA (90). These cytokines were, themselves, implicated in the
S6
-induction of LC depletion from the epidermis since depletion could be inhibited by anti-
bodies specific for these cytokines (90). One of the focuses of this study was to examine
T cell cytokine secretion in epidermal cell suspensions in the presence of SEA. It is
known that DETC have the capacitiy to produce IFNy and IL-2 (41, 106, 64, 105), al-
though it is unclear as to whether or not they produce IL-1 0, as well. Our studies focused
on the SEA-induced secretion of these three cytokines by epidermal cells, but results sug-
gest that the cytokine production observed in these epidermal cell cultures did not require
stimulation by SEA. Over a 48 hour period, levels of INFy and IL-2 accumulated in in-
creasing amounts, both SEA-treated and control groups. The student t-test was per-
formed and it was determined that the differences between the SEA and control groups
were not statistically significant. These results were consistently seen in three separate ex-
periments and it was first thought that bacterial pyrogen contamination may have contrib-
uted to the elevated cytokine levels in the controls. However, a repeat of these
experiments first using certified pyrogen-free tissue culture media and second, using media
which had been passed over an endotoxin-depleting column proved ineffective at bringing
control group levels down. It is possible that the conditions for obtaining the cell suspen-
sions could be contributing to the production of activating factors responsible for the level
of cytokine production observed in these studies. During epidermal cell suspension prepa-
ration, tissue is floated on a trypsin solution and the epidermis mechanically disrupted by
glass rod scraping and syringe aspiration. It is very likely that during this preparation, a
number of cells are damaged or destroyed, These cells could be producing substances
such as heat shock proteins in response to this stress since it has been hypothesized that
DETC play an active role in immune surveillance by recognizing heat shock proteins ex-
pressed by damaged or transformed cells (4). Also, it has been shown that DETC are able
to respond to certain Mycobacterial antigens that are considerably similar to heat shock
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proteins (66, 73). It may be possible that breakdown products of collagen, elastin or
other cellular debris from damaged epidermal cells released into the culture may be acti-
vating either DETC directly or indirectly through the induction of cytokine release from
LC or keratinocytes. It has been shown that cell separation techniques involving the pass-
ing of cells through glass wool and/or nylon columns could cause lymphocyte activation
(113). Therefore, the culture techniques used here may result in the activation signals to
DETC for cytokine secretion. Another possibility is that these cytokine levels are consti-
tutive, but this is probably unlikely, especially with IL-2 since it is usually only found after
cell stimulation of normal circulating T lymphocytes (93) and DETC (64, 72). Although
SEA was not the likely source of the activation of these cells, the cytokine pattern ex-
pressed is consistent with a cell-mediated immune response which is expressed in the skin
(100) Both IFNy and IL-2 are of the Thl cytokine profile, which promote a T cell-
mediated immune response (30, 93). It is known that within the dermis and epidermis,
only CD4+ and CD8+ T lymphocytes have been found -- as well as DETC in mice. There
is a complete lack of B cells within this region (100). Also, contact hypersensitivity falls
under the class of Type IV (delayed) hypersensitivity, which is the only type of hypersensi-
tivity which is cell mediated (83). The IL-IO studies included in these experiments further
support this cell-mediated theory, since IL-I 0 is a Th2 type cytokine and its activities in-
clude the downregulation of Th I type immune responses (83, 68).
The investigations previously described in this study have demonstrated an inability
of SEA to affect particular functions of DETe. One of the basic questions that must be
addressed in examining a role of DETC modulation by SEA is whether or not SEA binds
directly to the cell itself. In a further attempt to determine whether or not any interaction
exists between SEA and DETC, binding studies were performed using immunofluorescent
antibody staining. The results determined that no epidermal cells were simultaneously
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-positive for Thy-l.2 surface antigen and SEA binding. In other words, cells either bound
SEA or anti-Thy-l.2 antibody, but not both. This would suggest that DETC do not pos-
sess a receptor specific for SEA. If this is true, the results from the depletion studies and
cytokine production studies would make perfect sense since SEA was determined in these
experiments to be unable to bind to DETC. The interactions between staphylococcal su-
perantigens and normal circulating alB T lymphocytes has been well-studied and docu-
mented. However, many areas in y/8 T cell-superantigen interactions remain unclear.
Furthermore, most superantigen studies performed with y/8 T cells have been in the human
system and not in mice. Those studies have demonstrated, with some consistency, a ca-
pacity for staphylococcal enterotoxins to activate certain y/8 T cell clones. Most work in
this area has shown that clones bearing the Vy9 designation are the most reactive toward
these toxins, SEA in particular (86, 87, 79, 59). They also appear to act independent of
the J and C region of the y chain or the 8 chain altogether (59). There is some evidence,
however, that T cells with y chain designations other than Vy9 can be activated by SEA
and that SEA is not necessarily the only staphylococcal superantigen that y8 reactive T
cells respond to (86, 99). If this is the case, DETC might be expected to exhibit reactivity
toward SEA. The TCR on DETC are highly conserved, to the point of being virtually
monomorphic and nearly all of these DETC bear y chains of the Vy3 designation (42, 5,
4, 108). In light of this, it would make sense that these studies would provide no positive
results in the modulation of DETC by SEA when only Vy9+ T cells seem to be activated
by SEA. The interpretation of these results would only hold true, however, if they could
be carried across the human-mouse species barrier since all of the data implicating Vy9 as
the lone target for SEA on y8 T cells has been demonstrated in humans. There is certainly
structural variability between homologous y chain designations in mice and humans and
so, the assumption carried over from the human studies that DETC should not become
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-activated in any way by SEA may not be valid. Conversely, it is known that staphylococ-
cal superantigens can stimulate T cells across species barriers (61), so SEA reactivity with
DETC may still be feasable. If direct interaction of DETC with SEA does not occur, there
is still a possibility for DETC to be activated by signals from other cells within its environ-
ment when they have been activated by the toxin. It is known that IL-7 and TNFa pro-
mote the growth of DETC (63) and IL-l has been shown to have a proliferative effect
(110) on these cells, as well. All of these cytokines are produced by cells that share the
epidermal microenvironment with DETC (65) and it has been shown that at least IL-l a
and TNFa can be induced in epidermali cells by SEA stimulation (91). The possible indi-
rect effect of DETC stimulation or activation by SEA is unlikely in the present studies,
though, since results in each independent study were negative, Without observable ef-
fects on DETC in these studies, no source for modulation need be explored, However, no
dose response curves were persued in the migration and cytokine studies and it is possible
that DETC may be modulated by SEA, but only in appropriate concentrations, which were
not employed in these studies. In the depletion studies, SEA was applied to skjn sections
at a concentration of 100 !lg/ml, although it is difficult to say how much of the toxin is
penetrating the outer epidermis to reach the suprabasilar compartment occupied by DETC.
This concentration applied to skin was sufficient, though, to induce significant depletion of
LC from the epidermis (80). Also, SEA-induced cytokine secretion by LC was most ef-
fective at a final concentration in culture of 5 !lg/ml (91). This same concentration of
SEA was employed in the present cytokine studies based on the prior success in using it
with LC. This, too, may be an improper concentration for inducing cytokine secretion by
DETC, though. One experiment was performed using 10 !lg/ml SEA for DETC cytokine
induction, but showed results no different than those described here (data not shown).
Concentrations of SEA lower than 5 !lg/ml were not used, but it may be possible that only
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-significantly lower concentrations of SEA would yield positive results. Studies with hu-
man yo T cells determined SEA ranges of 0.01-1 J..lg/ml to be most effective (86, 87, 99)
and similar concentrations of SEA may be needed to induce a response in DETC.
In summary, DETC numbers were not reduced in the epidermis, either in vitro or
in vivo, by SEA application to the skin, although identical applications of SEA does sig-
nificantly reduce the number of Langerhans cells. It is entirely possible that even if SEA
were found to bind to DETC that it would not cause them to deplete or migrate from the
epidermis, as their main function may not require such action. DETC are the only epider-
mal cells capable of producing IL-2 and IFNy and our ELISA studies showed that they are
capable of secreting both of these cytokines, over time, in culture. Also, these results sup-
port that fact that T cell responses within the skin are of the Thl variety and IL-2 and
IFNy fall under the Th1 cytokine profile. This is also supported by the absence in produc-
tion of IL-1 0, a Th2-type cytokine and would be consistent since the expression of either
cytokine class is normally mutually exclusive in relation to the other (83). However, the
cytokine production observed was probably not due to SEA, but some other stimulatory
factor in culture since experimental and control groups of both cytokine studies exhibited
increased cytokine production over the course of the 48 hour study. Contaminating bacte-
rial endotoxins were ruled out as a stimulus of cytokine release through experimentation,
but cells stressed or mechanically damaged through the protocol could have contributed,
in some fashion, the stimulus necessary for DETC activation in culture. In performing
double immunoflourescent staining of epidermal cells for SEA and Thy-l surface antigen,
it was determined that there were no cells that were positive for both fluorescent markers
used. We therefore concluded that DETC did not bind SEA. This would be consistent
with literature which states that only Vy9+ y8 T cells respond to SEA since virtually all
DETC are Vy3+. However, these data were obtained using human, not murine, y8 T cells
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and these results do not prove the findings of the previous experiments, but they do sup-
port them. No literature was found to determine ifDETC respond in any way to SEA, or
to superantigens, in generaL All of these results would indicate that SEA does not modu-
late, or interact with, DETC. These studies are the first to address DETC-superantigen
interaction and provide preliminary evidence in determining as to whether SEA can modu-
late DETC function.
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